腎病綜合征-英文PPT_第1頁(yè)
腎病綜合征-英文PPT_第2頁(yè)
腎病綜合征-英文PPT_第3頁(yè)
腎病綜合征-英文PPT_第4頁(yè)
腎病綜合征-英文PPT_第5頁(yè)
已閱讀5頁(yè),還剩38頁(yè)未讀, 繼續(xù)免費(fèi)閱讀

下載本文檔

版權(quán)說(shuō)明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

NephroticsyndromeFigure1.Nephroticedema.Figure2.Nephroticedema.ClinicalSyndrome腎臟及泌尿系疾病經(jīng)常會(huì)引起一些臨床癥狀、體征和實(shí)驗(yàn)室表現(xiàn)相似的綜合征。識(shí)別患者屬于哪一種綜合征對(duì)診斷很有幫助,因?yàn)閷?dǎo)致每個(gè)綜合征的病因較之其包含的個(gè)別臨床癥狀和體征的致病原因要少,故識(shí)別患者屬于哪一種綜合征對(duì)診斷有幫助。ThemostcommonsyndromeofkidneydiseaseNephroticsyndromeNephriticsyndromeAsymptomaticurinaryabnormalitiesAcuterenalfailureorRapidlyprogressiverenalfailureChronickidneydisease(Table1)

(一)腎病綜合征(二)腎炎綜合征(三)無(wú)癥狀性尿檢異常(四)急性及急進(jìn)性腎衰竭綜合征(五)慢性腎臟病(表1)腎臟疾病常見綜合征Table1.STAGESOFCHRONICKIDNEYDISEASE*STAGEDESCRIPTIONGFR(mL/min/1.73m2)1Kidneydamagewithnormalor↑GFR≥902Kidneydamagewithmildor↓GFR60-893Moderate↓GFR30-594Severe↓GFR15-295Kidneyfailure<15(ordialysis)*ChronickidneydiseaseisdefinedaseitherkidneydamageorGFR<60mL/min/1.73m2for≥3months.Kidneydamageisdefinedaspathologicabnormalitiesormarkersofdamage,includingabnormalitiesinbloodorurinetestsorimagestudies.Nephroticsyndrome

Thisischaracterizedbyproteinuria(Typically>3.5g/24h),

hypoalbuminemia(lessthan30g/dL)andedema.

Hyperlipidaemiaisalsopresent.PrimaryandsecondarycausesaresummarizedinTable2,3

Inpractice,manycliniciansreferto“nephroticrange”proteinuriaregardlessofwhethertheirpatientshavetheothermanifestationsofthefullsyndromebecausethelatterareconsequencesoftheproteinuria.NEPHROTICSYNDROME

PathophysiologyProteinuriaHypoalbuminemiaEdemaHyperlipidemia

Cause(diagnosisanddifferentialdiagnosis)Systemicrenaldisease

hepatitisBassociatedglomerulonephritis,Henoch-Schonlein

purpura,systemiclupuserythematosus,diatetesmellitus,amyloidosisIdiopathicnephroticsyndrome

ComplicationsInfectionCoagulationdisordersProteinmalnutritionanddyslipidemiaAcuterenalfailure

PathophysiologyProteinuriaProteinuriacanbecausedbysystemicoverproduction,tubulardysfunction,orglomerulardysfunction.Itisimportanttoidentifypatientsinwhomtheproteinuriaisamanifestationofsubstantialglomerulardiseaseasopposedtothosepatientswhohavebenigntransientorpostural(orthostatic)proteinuria.Heavyproteinuria(albuminuria)Figure3.HypoalbuminemiaHypoalbuminemiaisinpartaconsequencesofurinaryproteinloss.Itisalsoduetothecatabolismoffilteredalbuminbytheproximaltubuleaswellastoredistributionofalbuminwithinthebody.Thisinpartaccountsfortheinexactrelationshipbetweenurinaryproteinloss,theleveloftheserumalbumin,andothersecondaryconsequencesofheavyalbuminuria.

ThesaltandvolumeretentionintheNSmayoccurthroughatleasttwodifferentmajormechanisms.Intheclassictheory,proteinurialeadstohypoalbuminemia,alowplasmaoncoticpressure,andintravascularvolumedepletion.Subequent

underperfusionofthekidneystimulatestheprimingofsodium-retentivehormonalsystemssuchastheRASaxis,causingincreasedrenalsodiumandvolumeretention,Intheperipheralcapillarieswithnormalhydrostaticpressuresanddecreasedoncoticpressure,theStarlingforcesleadtotranscapillaryfluidleakageandedema.EdemaInsomepatients,however,theintravascularvolumehasbeenmeasuredandfoundtobeincreasedalongwithsuppressionoftheRASaxis.Ananimalmodelofunilateralproteinuriashowsevidenceofprimaryrenalsodiumretentionatadistalnephronsite,perhapsduetoalteredresponsivenesstohormonessuchasatrial

natriureticfactor.Hereonlytheproteinurickidneyretainssodiumandvolumeandatatimewhentheanimalisnotyethypoalbuminemic.Thus,localfactorswithinthekidneymayaccountforthevolumeretentionofthenephroticpatientaswell.EdemaFigure4.HyperlipidemiaMostnephroticpatientshaveelevatedlevelsoftotalandlow-densitylipoprotein(LDL)cholesterolwithlowornormalhigh-densitylipoprotein(HDL)cholesterol.Lipoprotein(a)[Lp(a)]levelsareelevatedaswellandreturntonormalwithremissionofthenephroticsyndrome.Nephroticpatientsoftenhaveahypercoagulablestateandarepredisposedtodeepveinthrombophlebitis,pulmonaryemboli,andrenalveinthrombosis.CauseTable2CAUSESOFTHENEPHROTICSYNDROMETable3aNEPHROTICSYNDROMEASSOCIATEDWITHSPECIFICCAUSES(“SECONDARY”NEPHROTICSYNDROME)Table3bNEPHROTICSYNDROMEASSOCIATEDWITHSPECIFICCAUSES(“SECONDARY”NEPHROTICSYNDROME)

Pathologypatternsandclinicalpresentationsofidiopathicnephrotic

syndomeInadults,thenephroticsyndromeisacommonconditionleadingtorenalbiopsy.Inmanystudies,patientswithheavyproteinuriaandthenephroticsyndromeshavebeenagrouphighlylikelytobenefitfromrenalbiopsyintermsofachangeinspecificdiagnosis,prognosis,andtherapy.Selectedadultnephroticpatientssuchastheelderlyhaveaslightlydifferentspectrumofdisease,butagaintherenalbiopsyisthebestguidetotreatmentandprognosis(Table2,3).RenalbiopsyPRIMARYNEPHROTICSYNDROME

MinimalChangeDiseaseFocalSegmentalGlomerulosclerosisMembranousNephropathy

Membranoproliferative

Glomerulonephritis(MPGN)Figure5a.Pathologyofglomerulardisease.Lightmicroscopy.(a)Normalglomerulus;minimalchangedisease.Table4PRIMARYNEPHROTICSYNDROME

MinimalChangeDisease

FocalSegmentalGlomerulosclerosisMembranousNephropathy

Membranoproliferative

Glomerulonephritis(MPGN)Figure5b.Segmentalsclerosis;focalsegmentalglomerulosclerosis.Figure6.Lightmicroscopicappearancesinfocalsegmentalglomerulosclerosis.Segmentalscarswithcapsularadhesionsinotherwisenormalglomeruli.Table5PRIMARYNEPHROTICSYNDROME

MinimalChangeDiseaseFocalSegmentalGlomerulosclerosis

MembranousNephropathy

Membranoproliferative

Glomerulonephritis(MPGN)Figure7a.EarlyMN:aglomerulusfromapatientwithseverenephroticsyndromeandearlyMN,exhibitingnormalarchitectureandperipheralcapillarybasementmembranesofnormalthickness(Silver–methenamine×400).Figure7bmorphologicallyadvancedMNFigure7c.MorphologicallymoreadvancedMN(samepatientasin(b))Table6PRIMARYNEPHROTICSYNDROME

MinimalChangeDiseaseFocalSegmentalGlomerulosclerosisMembranousNephropathy

Membranoproliferative

Glomerulonephritis(MPGN)Figure8.Pathologyofmembranoproliferative

glomerulonephritistypeI.(a)Lightmicroscopyshowsahypercellular

glomeruluswithaccentuatedlobulararchitectureandasmallcellularcrescent(methenaminesilver).Table7DiagnosisandDifferentialdiagnosis

Initialevaluationofthenephroticpatientincludeslaboratoryteststodefinewhetherthepatienthasprimary,idiopathicnephroticsyndromeorasecondarycauserelatedtoasystemicdisease.Commonscreeningtestsincludethefastingbloodsugarandglycosylatedhemoglobintestsfordiabetes,andantinuclearantibodytestforrheumatoiddisease,andtheserumcomplement,whichscreenformanyimmunecomplex-mediateddisease(Table3),Inselectedpatients,cryoglobulins,hepatitisBandCserology,anti-neutrophil

cytoplasmicantibodies(ANCAS),antiGBMantibodies,andothertest

溫馨提示

  • 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

最新文檔

評(píng)論

0/150

提交評(píng)論